An estimation of statistical power, assuming a standard deviation based of the effects sizes found in a previous review of the Norwegian data (multiplied by a factor of 3 in order to achieve a more conservative estimate), suggests that power is well above 80% (approx. 98%). As is customary, no separate power estimation has been made for the health economics evaluation at this point as it will largely be based on the clinical effect data.